HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES By Investing.com

PLYMOUTH MEETING, Pa., Nov. 21, 2024 /PRNewswire/ —  Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony (JO:)’s management team will participate in the following upcoming investor conferences:

Citi’s 2024 Global Healthcare Conference

• Location:  Miami
• Tuesday, December 3, 2024

Piper Sandler 36^th Annual Healthcare Conference

• Location:  New York City
• Fireside Chat:  Wednesday, December 4, 2024, at  8:30 a.m., ET

A webcast of the fireside chat will be available on the investor page of Harmony’s website at https://ir.harmonybiosciences.com/.

About  Harmony Biosciences
Harmony Biosciences  is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked,  Harmony Biosciences  is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by  Paragon Biosciences, LLC, in 2017 and headquartered in  Plymouth Meeting, PA, we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visit  www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Brennan Doyle484-539-9700
bdoyle@harmonybiosciences.com

Harmony Biosciences Media Contact:Cate McCanless202-641-6086
cmccanless@harmonybiosciences.com